Morning Overview on MSN

Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial

The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked ...
MIT Technology Review

The first human test of a rejuvenation method will begin “shortly”

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...